South America Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)   

Code: BMIRE00027290 | Pages: 135 | Industry: Pharmaceuticals | Date: Oct 2022 | Type: Regional

The SAM doxorubicin market is expected to grow from US$ 65.06 million in 2022 to US$ 86.34 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.

 

Both chemotherapy and targeted therapy significantly improve cancer patients' chances of survival and quality of life. These therapies may bring about the complete remission of a tumor. Owing to these benefits, the demand for chemotherapy has surged across the region. Advanced cancer treatments improve patient survival and increase long-term outpatient chemotherapy requirements. More exposure to chemotherapy results in a greater demand for doxorubicin drugs, thereby boosting the market growth across the region.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM doxorubicin market. The SAM doxorubicin market is expected to grow at a good CAGR during the forecast period. 

 

SAM Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)  

Get more information on this report :

      

 

 

SAM Doxorubicin Market Segmentation                 

 

The SAM doxorubicin market is segmented based on drug formulation, application, distribution channel, and country. Based on drug formulation, the SAM doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. The lyophilized powder segment dominated the market in 2022. Based on application, the SAM doxorubicin market is segmented into breast cancer, kidney cancer, liver cancer, sarcoma, ovarian cancer, lung cancer, leukemia, multiple myeloma, and others. The breast cancer segment dominated the market in 2022. Based on distribution channel, the SAM doxorubicin market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2022. Based on country, the SAM doxorubicin market has been categorized into Brazil, Argentina, and rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.   

 

Accord Healthcare; Baxter International Inc.; Cipla Inc.; Dr. Reddy's Laboratories; Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Meiji Holdings Co., Ltd.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd; and Zydus Cadila are among the leading companies in the SAM doxorubicin market.  

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Doxorubicin Market – By Drug Formulation

1.3.2        SAM Doxorubicin Market – By Application

1.3.3        SAM Doxorubicin Market – By Distribution Channel

1.3.4        SAM Doxorubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Doxorubicin Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           SAM Doxorubicin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Increasing Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Potential Side-effects Associated with Doxorubicin

5.3         Market Opportunities

5.3.1        Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention

5.4         Future Trends

5.4.1        Increasing Approval of Generic Products

5.5         Impact Analysis

6.           Doxorubicin Market– SAM Analysis

6.1         SAM Doxorubicin Market Revenue Forecast and Analysis

7.           SAM Doxorubicin Market Analysis – By Drug Formulation

7.1         Overview

7.2         SAM Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)

7.3         Lyophilized Powder

7.3.1        Overview

7.3.2        Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

7.4         Doxorubicin Injection

7.4.1        Overview

7.4.2        Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.           SAM Doxorubicin Market Analysis – By Application

8.1         Overview

8.2         SAM Doxorubicin Market Share, By Application 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.4         Kidney Cancer

8.4.1        Overview

8.4.2        Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.5         Liver Cancer

8.5.1        Overview

8.5.2        Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.6         Sarcoma

8.6.1        Overview

8.6.2        Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.7         Ovarian Cancer

8.7.1        Overview

8.7.2        Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.8         Lung Cancer

8.8.1        Overview

8.8.2        Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.9         Leukemia

8.9.1        Overview

8.9.2        Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.10      Multiple Myeloma

8.10.1     Overview

8.10.2     Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.11      Others

8.11.1     Overview

8.11.2     Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.           SAM Doxorubicin Market Analysis – By Disribution Channel

9.1         Overview

9.2         SAM Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

10.        SAM Doxorubicin Market Analysis – By Country

10.1      Overview

10.1.1     SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)

10.1.1.1       Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Brazil: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.1.4       Brazil: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       Brazil: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.2       Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Argentina: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.2.4       Argentina: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       Argentina: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.3       Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Rest of SAM: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.3.4       Rest of SAM: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       Rest of SAM: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Accord Healthcare

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Cipla Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Meiji Holdings Co., Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Novartis AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pfizer Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Sun Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Baxter International Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Zydus Cadila

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             SAM Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Brazil: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of SAM: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of SAM: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of SAM Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done By Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           SAM Doxorubicin Market Segmentation

Figure 2.           SAM Doxorubicin Market Segmentation, By Country

Figure 3.           SAM Doxorubicin Market Overview

Figure 4.           SAM Doxorubicin Market, By Drug Formulation

Figure 5.           SAM Doxorubicin Market, By Country

Figure 6.           SAM: PEST Analysis

Figure 7.           SAM Doxorubicin Market Impact Analysis Of Driver And Restraints

Figure 8.           SAM Doxorubicin Market– Revenue Forecast and Analysis

Figure 9.           SAM Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)

Figure 10.        SAM Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        SAM Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        SAM Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)

Figure 13.        SAM Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        SAM Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        SAM Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 16.        SAM Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        SAM Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        SAM Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        SAM Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        SAM Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 21.        SAM Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        SAM Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)

Figure 23.        SAM Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        SAM Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 25.        SAM Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 26.        SAM: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)

Figure 27.        SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)

Figure 28.        Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

  1. Accord Healthcare
  2. Baxter International Inc.
  3. Cipla Inc.
  4. Dr. Reddy's Laboratories
  5. Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)   
  6. Meiji Holdings Co., Ltd.   
  7. Novartis AG   
  8. Pfizer Inc. 
  9. Sun Pharmaceutical Industries Ltd
  10. Zydus Cadila   
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000